Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Glandular Cell Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Glandular Cell Neoplasm

Cancer Family

Glandular Cell Neoplasm

CI-CAN-00000188Explore in graph →

Non-malignant2,823 active trials43 approved drugs426 evidence items

NCIt: C7132

Overview
Statistics
Survival
Genomics166
Variants & evidence426
Drugs106
Trials10205
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (384)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 26, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 376–384 of 384 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

TCGA, Nature 2017
· 2017 · PMID 28052061 · validated cbioportal_study pubmed
TCGA, Cell 2014
· 2014 · PMID 25417114 · validated cbioportal_study pubmed
Le Gallo et al. Cancer 2017
· 2017 · PMID 28485815 · validated cbioportal_study pubmed
Chen et al. Nat Commun 2016
· 2016 · PMID 27713405 · validated cbioportal_study pubmed
Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response.
· Cancer Med · 2023 · PMID 37260182 · validated civic_curation pubmed
High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients.
· J Transl Med · 2024 · PMID 39639373 · validated civic_curation pubmed
TMB as a predictive biomarker for ICI response in TNBC: current evidence and future directions for augmented anti-tumor responses.
· Clin Exp Med · 2025 · PMID 41249701 · validated civic_curation pubmed
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration.

Showing 376–384 of 384 publications

← Previous
1
…
15
16
Next →

· NPJ Precis Oncol · 2023 · PMID 36964191 · validated civic_curation pubmed

Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach.

· Front Immunol · 2026 · PMID 42158873 · validated civic_curation pubmed